Cargando…

Эндокринные нарушения после комбинированной химиолучевой терапии у больных лимфомой Ходжкина

BACKGROUND: BACKGROUND: Hodgkin’s lymphoma (HL) is one of the most common malignant lymphoproliferative diseases. Chemotherapy and radiotherapy used in the treatment of LH induce a number of toxic effects leading to dysfunction of endocrine system. Hormonal disorders in HL and their relationships wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Войтко, М. С., Климонтов, В. В., Поспелова, Т. И., Шебуняева, Я. Ю., Фазуллина, О. Н.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrinology Research Centre 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204787/
https://www.ncbi.nlm.nih.gov/pubmed/37448267
http://dx.doi.org/10.14341/probl13124
_version_ 1785045905545625600
author Войтко, М. С.
Климонтов, В. В.
Поспелова, Т. И.
Шебуняева, Я. Ю.
Фазуллина, О. Н.
author_facet Войтко, М. С.
Климонтов, В. В.
Поспелова, Т. И.
Шебуняева, Я. Ю.
Фазуллина, О. Н.
author_sort Войтко, М. С.
collection PubMed
description BACKGROUND: BACKGROUND: Hodgkin’s lymphoma (HL) is one of the most common malignant lymphoproliferative diseases. Chemotherapy and radiotherapy used in the treatment of LH induce a number of toxic effects leading to dysfunction of endocrine system. Hormonal disorders in HL and their relationships with the therapy used remain to be clarified. AIM: AIM: To assess disorders of the endocrine function of thyroid, parathyroid glands and gonads in HL survivors. MATERIALS AND METHODS: MATERIALS AND METHODS: Screening of endocrine dysfunction of the thyroid, parathyroid glands and gonads was performed in 160 adult patients with HL, 55 men and 105 women, at remission stage induced by chemotherapy or chemoradiotherapy. Forty healthy subjects, matched by age, were acted as control. The levels of TSH, T3, free T4, PTH, FSH, LH, free testosterone, dehydroepiandrosterone sulfate (DHEA-S), and sex-hormone binding globulin (SHBG) were measured in blood serum by ELISA. Bone mineral density (BMD) was assessed by DEXA. RESULTS: RESULTS: Hypothyroidism (25%), hyperparathyroidism (15.6%) and hypogonadism (29% of men and 25.3% of women) were the most prevalent endocrine disorders in LH survivors. Hypothyroidism was significantly more common in patients after chemoradiotherapy than in those who received only chemotherapy (χ2=9.4, р=0.002). In patients with hyperparathyroidism, there were negative correlations between PTH levels and BMD in the lumbar spine (r=-0.74, p=0.00002) and in the femoral neck (r=-0.66, p=0.0003). Men with HL demonstrated lower free testosterone concentrations when compared to control (p=0.04); LH and FSH levels were elevated (p=0.0004 and p=0.04, respectively). In men with HL the levels of DHEA-S were reduced (p=0.0009). The increased SHBG concentrations were revealed in 13 (23.6%) men. Women of reproductive age with HL had higher levels of LH in the luteal phase (p=0.05) and FSH in the follicular phase (p=0.02) than controls. CONCLUSION: CONCLUSION: The data indicate a high prevalence of the dysfunctions of thyroid, parathyroid glands, and gonads in HL survivors. Screening for endocrine disorders in these patients is highly recommended.
format Online
Article
Text
id pubmed-10204787
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Endocrinology Research Centre
record_format MEDLINE/PubMed
spelling pubmed-102047872023-05-24 Эндокринные нарушения после комбинированной химиолучевой терапии у больных лимфомой Ходжкина Войтко, М. С. Климонтов, В. В. Поспелова, Т. И. Шебуняева, Я. Ю. Фазуллина, О. Н. Probl Endokrinol (Mosk) Research Article BACKGROUND: BACKGROUND: Hodgkin’s lymphoma (HL) is one of the most common malignant lymphoproliferative diseases. Chemotherapy and radiotherapy used in the treatment of LH induce a number of toxic effects leading to dysfunction of endocrine system. Hormonal disorders in HL and their relationships with the therapy used remain to be clarified. AIM: AIM: To assess disorders of the endocrine function of thyroid, parathyroid glands and gonads in HL survivors. MATERIALS AND METHODS: MATERIALS AND METHODS: Screening of endocrine dysfunction of the thyroid, parathyroid glands and gonads was performed in 160 adult patients with HL, 55 men and 105 women, at remission stage induced by chemotherapy or chemoradiotherapy. Forty healthy subjects, matched by age, were acted as control. The levels of TSH, T3, free T4, PTH, FSH, LH, free testosterone, dehydroepiandrosterone sulfate (DHEA-S), and sex-hormone binding globulin (SHBG) were measured in blood serum by ELISA. Bone mineral density (BMD) was assessed by DEXA. RESULTS: RESULTS: Hypothyroidism (25%), hyperparathyroidism (15.6%) and hypogonadism (29% of men and 25.3% of women) were the most prevalent endocrine disorders in LH survivors. Hypothyroidism was significantly more common in patients after chemoradiotherapy than in those who received only chemotherapy (χ2=9.4, р=0.002). In patients with hyperparathyroidism, there were negative correlations between PTH levels and BMD in the lumbar spine (r=-0.74, p=0.00002) and in the femoral neck (r=-0.66, p=0.0003). Men with HL demonstrated lower free testosterone concentrations when compared to control (p=0.04); LH and FSH levels were elevated (p=0.0004 and p=0.04, respectively). In men with HL the levels of DHEA-S were reduced (p=0.0009). The increased SHBG concentrations were revealed in 13 (23.6%) men. Women of reproductive age with HL had higher levels of LH in the luteal phase (p=0.05) and FSH in the follicular phase (p=0.02) than controls. CONCLUSION: CONCLUSION: The data indicate a high prevalence of the dysfunctions of thyroid, parathyroid glands, and gonads in HL survivors. Screening for endocrine disorders in these patients is highly recommended. Endocrinology Research Centre 2023-05-11 /pmc/articles/PMC10204787/ /pubmed/37448267 http://dx.doi.org/10.14341/probl13124 Text en Copyright © Endocrinology Research Centre, 2023 https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 License.
spellingShingle Research Article
Войтко, М. С.
Климонтов, В. В.
Поспелова, Т. И.
Шебуняева, Я. Ю.
Фазуллина, О. Н.
Эндокринные нарушения после комбинированной химиолучевой терапии у больных лимфомой Ходжкина
title Эндокринные нарушения после комбинированной химиолучевой терапии у больных лимфомой Ходжкина
title_full Эндокринные нарушения после комбинированной химиолучевой терапии у больных лимфомой Ходжкина
title_fullStr Эндокринные нарушения после комбинированной химиолучевой терапии у больных лимфомой Ходжкина
title_full_unstemmed Эндокринные нарушения после комбинированной химиолучевой терапии у больных лимфомой Ходжкина
title_short Эндокринные нарушения после комбинированной химиолучевой терапии у больных лимфомой Ходжкина
title_sort эндокринные нарушения после комбинированной химиолучевой терапии у больных лимфомой ходжкина
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204787/
https://www.ncbi.nlm.nih.gov/pubmed/37448267
http://dx.doi.org/10.14341/probl13124
work_keys_str_mv AT vojtkoms éndokrinnyenarušeniâposlekombinirovannojhimiolučevojterapiiubolʹnyhlimfomojhodžkina
AT klimontovvv éndokrinnyenarušeniâposlekombinirovannojhimiolučevojterapiiubolʹnyhlimfomojhodžkina
AT pospelovati éndokrinnyenarušeniâposlekombinirovannojhimiolučevojterapiiubolʹnyhlimfomojhodžkina
AT šebunâevaâû éndokrinnyenarušeniâposlekombinirovannojhimiolučevojterapiiubolʹnyhlimfomojhodžkina
AT fazullinaon éndokrinnyenarušeniâposlekombinirovannojhimiolučevojterapiiubolʹnyhlimfomojhodžkina